Product Highlights
✔ Validated by WB on lysate from Zika virus-infected cells.
✔ Appear to distinguish between Zika, Dengue, and Chikungunya virus via IFA.
✔ An extensive line of research antibodies against different Zika virus proteins. |
| Zika virus (ZIKV) exploded into international prominence in 2015. This mosquito-borne flavivirus had its first reported outbreak in 2007, followed by a larger event in 2013 in French Polynesia and the present outbreak in Brazil. Nearly 70 countries and territories have documented ZIKV transmission since 2007. |
| While about 80% of ZIKV infections are asymptomatic, the virus can cause influenza-like symptoms and other clinical manifestations including conjunctivitis. Infection has been linked to cases of neurological disease, including Guillain-Barre syndrome. Most concerning is the increasingly robust evidence associating ZIKV with microcephaly (and other neurodevelopmental problems) in newborns from infected mothers. ZIKV infection is diagnosed by serological, cytokine profiling, and RT-PCR testing. The serological assays can be cumbersome and can fail to clearly identify ZIKV in the presence of Dengue or other flaviviruses, so RT-PCR is the most reliable method to specifically detect the virus. However, antibodies targeting different protein components of ZIKV would be immensely useful to facilitate both basic research and as potential diagnostic reagents. |
| GeneTex is proud to offer an extensive line of research antibodies to support the study of Zika virus. Please see the highlighted products below or Click here to view the full list of GeneTex antibodies against Zika virus proteins. |